Atomo Diagnostics (ASX:AT1) Raises A$4m as FebriDx CLIA Waiver Unlocks Pascal Volume Upside

Atomo Diagnostics A$4m Raise Funds Scale-Up as FebriDx US Rollout Accelerates Atomo Diagnostics has just completed a fresh capital raise to fund growth. The company raised A$4M through a A$3M…

ByCharlie Youlden

26

Feb 2025

Biotech Stocks Healthcare Stocks Small Caps Stocks

Atomo Diagnostics (ASX:AT1): Not just another Rapid Diagnostic (RDT) company

Atomo Diagnostics (ASX:AT1) may be written off by some investors just because it is a rapid test kit company. Yes, we know rapid COVID tests were a booming market during…

ByNick Sundich

24

Feb 2023

Life Sciences

Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?

In the past year, biotech shares have performed poorly. Why has this been the case and will things be better in 2023? SIGN UP FOR THE STOCKS DOWN UNDER NEWSLETTER NOW!…

ByNick Sundich

Atomo Diagnostics (ASX:AT1) Raises A$4m as FebriDx CLIA Waiver Unlocks Pascal Volume Upside

Atomo Diagnostics (ASX:AT1): Not just another Rapid Diagnostic (RDT) company

Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?

PLS Group (ASX:PLS) Hits Record High on...

Narryer Metals (ASX:NYM) Tim Goyder Back...

Sovereign Metals (ASX:SVM) DFS lands,$2....

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here